Mesalamine DR 1.2 GM tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FV8WM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,941
Award facts
- Contract value 100% obligated
- $1,940.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,940.56 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026, and was competitively awarded with no set-aside designation. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables comprehensive global pharmaceutical support to military healthcare programs and encompasses a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The contract supports critical medical supply chains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating AmerisourceBergen's significant role as a primary pharmaceutical vendor for Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FV8WM?
SPE2DR26FV8WM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FV8WM worth?
The government has obligated $1,941 on SPE2DR26FV8WM.
Is contract SPE2DR26FV8WM an order under another contract?
Yes. SPE2DR26FV8WM is a delivery order under SPE2DR25D7056, an indefinite delivery contract.
Was contract SPE2DR26FV8WM competed?
The extent of competition for SPE2DR26FV8WM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award